Aurobindo Pharma

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue2,6862,4862,7363,0233,017
Expenses1,9292,0602,2262,3362,237
EBITDA856.11517.26612.26812.82897.76
EBIT789.43457.63546.47748.47832.95
Profit Before Tax803.95443.99545.87687.22779.88
Net Profit644.97335.95415.74623.78578.67
Financial Ratios
Operating Profit Margin38.05%22.64%24.48%30.51%31.32%
Net Profit Margin25.24%13.45%14.34%23.42%20.19%
Earning Per Share (Diluted)11.005.747.1010.659.88
Dividends Per Share0.000.000.001.500.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ